Trials / Completed
CompletedNCT05309837
Effect of Polydextrose on Fecal Bulk and Bowel Function in Mildly Constipated Subjects
A Two-center, Randomized, Double-blind, Placebo Controlled, Parallel Study to Evaluate the Effect of Polydextrose on Fecal Bulk and Bowel Function in Mildly Constipated Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Tate & Lyle · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Polydextrose (PDX) (8-30g/day) has been reported to increase faecal bulk and consistency, leading to easier stool passage in healthy subjects. Studies on its effect on defaecation frequency and colonic transit time have provided mixed results. The primary objective was to investigate the effect of PDX consumption by mildly constipated subjects on faecal bulk, measured as total faecal wet weight of 4-day collections. Secondary outcomes (faecal dry weight, defaecation frequency, stool consistency, ease of stool passage, total colonic transit time and gastrointestinal symptoms) were also explored. 51 subjects participated in a 4-week, two-center, randomized, double-blind, placebo-controlled, parallel study testing a control (CON) and a PDX treatment (18 g/d included in biscuits and drink mixtures)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Polydextrose | Polydextrose-enriched food products |
| DIETARY_SUPPLEMENT | placebo-controlled | Control food products |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-05-01
- Completion
- 2013-09-19
- First posted
- 2022-04-04
- Last updated
- 2022-04-04
Source: ClinicalTrials.gov record NCT05309837. Inclusion in this directory is not an endorsement.